GlassScriptPhysician profile
Chuan Liang
NPI 1679984793
$20,536.15
in general payments reported to CMS, 2019-2025
13 companies · $6,368 in 2025
The $6,368 reported for 2025 was more than what 84% of Neuroradiology providers received nationally (typical 2025 total: $278).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $149 · 2022: $3,655 · 2023: $4,194 · 2024: $6,170 · 2025: $6,368.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Travel and Lodging: $4,889 · Consulting Fee: $1,800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,043.72 |
| Travel and Lodging | $4,888.70 |
| Consulting Fee | $1,800.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $7,032.68 | 2022-2025 | Penumbra System, Smart Coil, Benchmark |
| Imperative Care, INC | $3,297.71 | 2022-2025 | Zoom 88-T Large Distal Platform, Zoom Rdl Radial Access System, 103cm, Zoom Reperfusion Catheter |
| Stryker Corporation | $2,580.12 | 2022-2025 | Evolve, Spinejack, Surpass Evolve |
| Route 92 Medical, INC. | $2,117.78 | 2024-2025 | 8f Base Camp Sheath System |
| Microvention, INC. | $1,220.71 | 2022-2025 | Web Aneurysm Embolization System, Stent, Tubing Kit - Stroke |
| Depuy Synthes Sales INC. | $1,085.69 | 2022-2024 | Cerepak Uniform, Cerenovus Enterprise, Emboguard |
| Qapel Medical INC | $935.64 | 2023-2025 | |
| Balt USA, LLC | $791.70 | 2023-2024 | Optima Coil System |
| Siemens Medical Solutions USA, INC. | $693.56 | 2022-2023 | Corpath Imaging System |
| Medtronic, INC. | $585.27 | 2021-2023 | Pipeline |
| Scientia Vascular | $120.20 | 2025 | Socrates 38 |
| Abbott Laboratories | $75.09 | 2025 | Xact |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$899,987.04 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chuan Liang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.